A study by the University of the Basque Country (UPV/EHU) has identified the most relevant YouTube videos on this disease and the concerns of the people who post comments.
Sorrento goes to China with Covid drug; Vistagen touts early efficacy data on PMDD nasal spray
Sorrento Therapeutics’ oral Mpro inhibitor olgotrelvir has hit the primary endpoint and a key secondary endpoint in a Phase III trial that recruited adults with
September 14, 2023